Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yardeni

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|February 28, 2022
Review article: hepatitis B-current and emerging therapiesDavid Yardeni, Marc G Ghany
Journal of Viral Hepatitis|February 5, 2022
Chronic hepatitis D-What is changing?David Yardeni, Theo Heller, Christopher Koh
Gastroenterology|October 15, 2022
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for CureDavid Yardeni, Kyong-Mi Chang, Marc G Ghany
Hormone Research in Paediatrics|June 1, 2011
Ethnic and gender inequities in the evaluation of referred short childrenDavid Yardeni, Neta Loewenthal, Yehuda Limony, et al.
Biomedicines|April 27, 2024
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular CarcinomaOhad Etzion, Avital Bareket-Samish, David Yardeni, et al.
Archives of Gynecology and Obstetrics|February 14, 2024
The association between aspartate aminotransferase (AST) to platelets (PLT) ratio (APRI) and the development of intrahepatic cholestasis in pregnancy and other related complicationsRazan Saadi, Alla Saban, Adi Y Weintraub, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 13, 2020
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infectionDavid Yardeni, Vitali Dizengof, Anat Nevo-Shor, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 25, 2022
The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular MorbidityDavid Yardeni, Ronen Toledano, Victor Novack, et al.
ACG Case Reports Journal|October 17, 2022
Reversal of Clinically Significant Portal Hypertension After Immunosuppressive Treatment in a Patient With SarcoidosisDavid Yardeni, Julian Hercun, Gracia Viana Rodriguez, et al.
Scientific Reports|December 13, 2023
MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)David Yardeni, Adi Shiloh, Inna Lipnizkiy, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|February 28, 2022
Review article: hepatitis B-current and emerging therapiesDavid Yardeni, Marc G Ghany
Journal of Viral Hepatitis|February 5, 2022
Chronic hepatitis D-What is changing?David Yardeni, Theo Heller, Christopher Koh
Gastroenterology|October 15, 2022
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for CureDavid Yardeni, Kyong-Mi Chang, Marc G Ghany
Hormone Research in Paediatrics|June 1, 2011
Ethnic and gender inequities in the evaluation of referred short childrenDavid Yardeni, Neta Loewenthal, Yehuda Limony, et al.
Biomedicines|April 27, 2024
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular CarcinomaOhad Etzion, Avital Bareket-Samish, David Yardeni, et al.
Archives of Gynecology and Obstetrics|February 14, 2024
The association between aspartate aminotransferase (AST) to platelets (PLT) ratio (APRI) and the development of intrahepatic cholestasis in pregnancy and other related complicationsRazan Saadi, Alla Saban, Adi Y Weintraub, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 13, 2020
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infectionDavid Yardeni, Vitali Dizengof, Anat Nevo-Shor, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 25, 2022
The Association of Alanine Aminotransferase Levels With Myocardial Perfusion Imaging and Cardiovascular MorbidityDavid Yardeni, Ronen Toledano, Victor Novack, et al.
ACG Case Reports Journal|October 17, 2022
Reversal of Clinically Significant Portal Hypertension After Immunosuppressive Treatment in a Patient With SarcoidosisDavid Yardeni, Julian Hercun, Gracia Viana Rodriguez, et al.
Scientific Reports|December 13, 2023
MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)David Yardeni, Adi Shiloh, Inna Lipnizkiy, et al.
Pageof 3